Verity Asset Management, Inc. - CONTRA AVI GENOMIC MEDICINE INC ownership

Quarter-by-quarter ownership
Verity Asset Management, Inc. ownership history of CONTRA AVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q3 2023$4,4530.0%30,5000.0%0.00%0.0%
Q2 2023$4,4530.0%30,5000.0%0.00%0.0%
Q1 2023$4,4530.0%30,5000.0%0.00%
-25.0%
Q4 2022$4,453
-99.9%
30,5000.0%0.00%
-20.0%
Q3 2022$4,453,000
+88960.0%
30,5000.0%0.01%
+66.7%
Q1 2022$5,000
+25.0%
30,5000.0%0.00%
+50.0%
Q4 2021$4,0000.0%30,5000.0%0.00%
-33.3%
Q3 2021$4,0000.0%30,5000.0%0.00%
+50.0%
Q2 2021$4,0000.0%30,5000.0%0.00%0.0%
Q1 2021$4,0000.0%30,5000.0%0.00%
-33.3%
Q4 2020$4,0000.0%30,5000.0%0.00%0.0%
Q3 2020$4,0000.0%30,5000.0%0.00%
-25.0%
Q2 2020$4,0000.0%30,5000.0%0.00%
-20.0%
Q1 2020$4,00030,5000.01%
Other shareholders

There were no reported owners of CONTRA AVI GENOMIC MEDICINE INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of CONTRA AVI GENOMIC MEDICINE INC shareholders